Hi J8. I do think as laid out in my previous post that the company will be forced to implement a trading halt if early in v itro work demonstrates activity against the cloned corona virus. What with all kinds of theories out there in punterland, the stock will be too volatile.
With regard to tox studies, sure, these will need to be done but in all likelehood all of the compounds in the library will be of a similar structure and hence activity. Given that 225 is relatively benign, I'd be predicting all the other compounds are similarly benign.
Dr Michelle Miller talks on Heath kick Podcast, page-178
Add BIT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.5¢ |
Change
-0.002(3.51%) |
Mkt cap ! $49.62M | |||
| Open | High | Low | Value | Volume |
| 5.7¢ | 5.8¢ | 5.5¢ | $48.93K | 874.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 40549 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 126191 | 3 |
View Market Depth
| Last trade - 15.32pm 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
5.5¢ |
Change
-0.002 ( 3.51 %) |
||||
| Open | High | Low | Volume | ||
| 5.8¢ | 5.8¢ | 5.5¢ | 262949 | ||
| Last updated 15.32pm 17/05/2024 ? | |||||
| BIT (ASX) Chart |